RS Research Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
18
- Latest Deal Type
-
Series B
- (Upcoming)
- Investors
-
7
RS Research General Information
Description
Developer of nanomedicine technologies intended to enable targeted chemotherapy for cancer treatment. The company offers polymer-based drug conjugates and nanocarrier drug-delivery technology with targeted delivery capabilities, enabling medical researchers and oncology healthcare providers to study and administer chemotherapy with controlled drug targeting.
Contact Information
Website
www.rsresearch.netCorporate Office
- Teknopark Istanbul
- Sanayi Mahallesi Teknopark Boulevard. Number:1/2A-401
- 34912 Istanbul
- Turkey
Corporate Office
- Teknopark Istanbul
- Sanayi Mahallesi Teknopark Boulevard. Number:1/2A-401
- 34912 Istanbul
- Turkey
RS Research Timeline
RS Research Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series B) | Upcoming | Clinical Trials - Phase 1 | ||||
| 7. Grant | 31-Mar-2024 | Completed | Clinical Trials - Phase 1 | |||
| 6. Accelerator/Incubator | 05-Mar-2024 | Completed | Clinical Trials - Phase 1 | |||
| 5. Secondary Transaction - Private | 13-Jun-2023 | Completed | Clinical Trials - Phase 1 | |||
| 4. Later Stage VC (Series A) | 23-Dec-2021 | Completed | Clinical Trials - Phase 1 | |||
| 3. Early Stage VC | 29-Dec-2017 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 26-Sep-2017 | $1.31M | $1.31M | Completed | Pre-Clinical Trials | |
| 1. Accelerator/Incubator | Completed | Clinical Trials - Phase 1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
RS Research Signals
RS Research Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| European Innovation Council | Accelerator/Incubator | Minority | ||
| Turcorn 100 | Accelerator/Incubator | |||
| Eczacıbaşı Momentum | Corporate Venture Capital | Minority | ||
| Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret | Corporation | Minority | ||
| İstanbul Portföy Yönetimi | Asset Manager | Minority |
RS Research FAQs
-
When was RS Research founded?
RS Research was founded in 2015.
-
Where is RS Research headquartered?
RS Research is headquartered in Istanbul, Turkey.
-
What is the size of RS Research?
RS Research has 18 total employees.
-
What industry is RS Research in?
RS Research’s primary industry is Drug Discovery.
-
Is RS Research a private or public company?
RS Research is a Private company.
-
What is RS Research’s current revenue?
The current revenue for RS Research is .
-
How much funding has RS Research raised over time?
RS Research has raised $14.4M.
-
Who are RS Research’s investors?
European Innovation Council, Turcorn 100, Eczacıbaşı Momentum, Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret, and İstanbul Portföy Yönetimi are 5 of 7 investors who have invested in RS Research.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process